Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Monte Rosa Therapeutics Q2 2024 GAAP EPS $(0.43) Beats $(0.55) Estimate, Sales $4.695M Beat $1.349M Estimate, Cash Position Of $267.1M Is Expected To Fund Operations Into H1 2027

Author: Benzinga Newsdesk | August 08, 2024 08:12am

Posted In: GLUE